受賞

• 笠原浩生：第11回日本認知症予防学会学術集会　浦上賞

論文発表

英文

• Kasahara H, Shimizu K, Makioka K, Sano T, Ohtaki Y, Ikeda Y. Multimodal immunotherapy ameliorates myasthenia gravis preceded by thymoma-associated multiorgan autoimmunity. Immunol Res. 2022; 70: 414-418.
• Furuta M, Sato M, Tsukagoshi S, Tsushima Y, Ikeda Y. Criteria-unfulfilled multiple system atrophy at an initial stage exhibits laterality of middle cerebellar peduncles. J Neurol Sci. 2022; 438: 120281.
• Furuta M, Sato M, Kasahara H, Tsukagoshi S, Hirayanagi K, Fujita Y, Takai E, Aihara Y, Okamoto K, and Ikeda Y. Clinical, radiological, and molecular analyses of neuronal intranuclear inclusion disease with polyglycine inclusions. J Neurol Sci 2023;448:120618.
• Shibata M, Makioka K, Hamaguchi Y, Ikeda Y. Comment on: Favourable complete remission of anti-OJ antibody-positive myositis after lung cancer resection: Reply. Rheumatology (Oxford). 2022; 61: e235.
• Nakamura T, Kawarabayashi T, Ueda T, Shimomura S, Hoshino M, Itoh K, Ihara K, Nakaji S, Takatama M, Ikeda Y, and Shoji M. (in press) Plasma ApoE4 levels are lower than ApoE2 and ApoE3 levels, and not associated with plasma Aβ40/42 ratio as a biomarker of Aß amyloidosis in Alzheimer’s disease. J Alzheimers Dis.
• Kawarabayashi T, Nakamura T, Sato K, Seino Y, Ichii S, Nakahata N, Takatama M, Westaway D, George-Hyslop PS, Shoji M. Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer’s Disease Pathology. J Alzheimers Dis. 2022;87(3):1189-1203. doi: 10.3233/JAD-215662. PMID: 35431249.
• Maruyama K, Shibata M, Nagashima K, Abe T, Ikeda Y. A case of idiopathic intracardiac and pulmonary arterial thrombosis successfully treated with surgical thrombectomy. Neurology and Clinical Neuroscience. 2022; 10 (3): 167-169.
• Takazawa T, Horiuchi T, Orihara M, Nagumo K, Tomioka A, Ideno Y, Hayashi K, Yashima H, Araki T, Hatayama K, Terauchi M, Ikeda Y, Saito S. Prevention of Postoperative Cognitive Dysfunction by Minocycline in Elderly Patients after Total Knee Arthroplasty: A Randomized, Double-blind, Placebo-controlled Clinical Trial. Anesthesiology. 2023; 138: 172-183.

総説

• 池田佳生.　特集：神経疾患における遺伝医療の進歩　Ⅲ. 脊髄小脳変性症の治療開発の進歩.　日本内科学会雑誌　2022; 111: 1520-1526.
• 池田佳生.　特集：日本発の神経疾患－発見の歴史からのメッセージ　SCA36－臨床・原因究明の歴史.　CLINICAL NEUROSCIENCE　2023; 41: 40-43.
• 塚越設貴, 池田佳生.　脊髄疾患・脊髄症状を呈する脊椎疾患－症状と治療　放射線脊髄症.　Clinical Neuroscience　中外医学社　2022, Vol 40 No 11 pp1421-23.

著書

• Makioka K, Yamazaki T, Sato M, Takatama M, Okamoto K, Ikeda Y. CHAPTER 10; Granulovacuolar degeneration in neurodegeneration; AUTOPHAGY DYSFUNCTION IN ALZHEIMER’S DISEASE AND DEMENTIA. ELSEVIER (ACADEMIC PRESS), 2022, pp 167-206.

市民講演会や患者会での講演

• 池田佳生.　脊髄小脳変性症・多系統萎縮症と上手につきあうために.　2022年度　つくしの会医療講演会　2023.3.12（前橋）
• 古田みのり. 多系統萎縮症・脊髄小脳変性症について. 難病（多系統萎縮症・脊髄小脳変性症）療養相談会・交流会　2022.6.1（前橋）